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Accepted 12 October 2012AbstractObjective: Congenital cystic adenomatoid malformation of the lung (CCAML) is one of the most common lung lesions diagnosed prenatally. In
order to compare the trends and improvements of prenatal diagnosis of CCAML, we herein retrospectively reviewed our cases of fetal CCAML
detected by three-dimensional ultrasound (3-D US) between two centuries.
Materials and Methods: We reviewed our computer database of prenatal diagnosis of CCAML in National Cheng Kung University Hospital from
October 1994 to November 2011. All of the fetuses were initially scanned by two-dimensional (2-D) US to locate the region-of-interest (ROI).
Then, the 3-D probe was used to scan all of the ROI systematically and mechanically, and the images were stored in the laser discs for further 3-
D visualization and reconstruction. To compare the characteristics at prenatal diagnosis of CCAML between the 20th and 21st centuries in our
hospital, Chi-square tests were undertaken. A p value <0.05 was considered as statistically significant.
Results: In total, 58 fetuses with CCAML were depicted by 3-D US in utero (12 cases were diagnosed in the 20th century and 46 cases in the 21st
century). The ranges of gestational age at prenatal diagnosis of CCAML by 3-D US in the 20th century were between 15 and 36 weeks
(mean¼ 24 weeks), and were between 16 and 31 weeks (mean¼ 22 weeks) in the 21st century. Moreover, nine cases (75%) were diagnosed at
the second trimester in the 20th century, whereas 44 cases (96%) were diagnosed at the second trimester in the 21st century.
Conclusion: The advancement of 3-D US has remarkable advantages in adding novel visual depiction of a 3-D lesion of a 3-D fetus in 3-D US
after reconstruction, and thus assists substantially in the prenatal diagnosis and genetic consultation of CCAML. Furthermore, the trend analysis
in this series showed a significantly earlier gestational age at prenatal diagnosis of CCAML in the 21st century than that in the 20th century.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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http://dx.doi.org/10.1016/j.tjog.2012.10.004prenatally, although the prevalence of CCAML is relatively
low (around 0.003e0.004%) [1,2]. CCAML is a devel-
opmental malformation of the lower respiratory tract, which
results from abnormalities of branching morphogenesis of the
lung. The different types of CCAML are considered to origi-
nate at different levels of the tracheobronchial tree and at
different stages of fetal lung development in utero [3e5].
CCAML is classified asmacrocystic ormicrocystic, based on
prenatal ultrasound appearance, and these masses are most
commonly identified in the second trimester [6]. Macrocystscs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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echogenic lung parenchyma. Microcysts (type III) appear as
a homogeneous and solid mass that is hyper-echogenic com-
pared to the adjacent normal lung parenchyma. Mixed lesions
also occur (type II). Some studies find that lesions regress during
the course of gestation in as many as 59% of cases [7e11].
Furthermore, complete spontaneous resolution in the postnatal
period has been reported in a small number of cases [6,10e13].
To date, three-dimensional ultrasound (3-D US) has been
applied in many fields. 3-D US can assess fetal organ volumes
and diagnose congenital anomalies in utero [19e30]. With
recent advancements of 3-D US, multiplanar orthogonal view,
as well as reconstruction of surface-rendering modes, become
feasible and have advantages in the differential diagnosis of
fetal chest masses [19e30]. In order to compare the trends and
improvements of prenatal diagnosis of CCAML, we herein
retrospectively reviewed our computer database of fetal
CCAML detected by 3-D US from 1994 to 2011.
Materials and methodsPatients and settingFrom October 1994 to November 2011, the records of pa-
tients with fetal CCAML by 3-D US were reviewed. In gen-
eral, the patients were referred from local practitioners or from
the Antenatal Care Clinic of National Cheng Kung University
Hospital. The setting was at the Prenatal Ultrasound Lab of the
Department of Obstetrics and Gynecology, National Cheng
Kung University Hospital, which is the largest national tertiary
medical center in Southern Taiwan. All of the fetuses were
followed to the end of pregnancy to confirm the diagnosis of
CCAML. Informed consent was given by the patients. The
study was approved by the Institutional Review Board, Na-
tional Cheng Kung University Hospital (IRB, ER-99-011).EquipmentWe used conventional 3-D US scanners for prenatal
screening. The 3-D US machines were Voluson 530D (Kretz,Table 1
Prenatal diagnosis of fetal congenital cystic adenomatoid malformation of the lun
Case no. Maternal
age (y)
Pregnancy
history
Gestational
age (wk)
US diagnos
1 29 G1P0 15 CCAML ty
2 31 G2P1 20 CCAML ty
3 27 G3P2 21 CCAML ty
4 21 G2P1 21 CCAML ty
5 25 G1P0 21 CCAML ty
6 23 G1P0 22 CCAML ty
7 31 G1P0 23 CCAML ty
8 29 G3P1A1 24 CCAML ty
9 32 G2P1 26 CCAML ty
10 32 G1P0 28 CCAML ty
11 34 G1P0 28 CCAML ty
12 22 G2P1 36 CCAML ty
CPC¼ choroid plexus cyst; EIF¼ echogenic intracardiac focus; Follow-up
TOP¼ termination of pregnancy; VBAC¼ vaginal birth after cesarean section; VDZipf, Austria), or Voluson 730 (GE, Milwaukee, WI, USA)
and Accuvix V20 (Medison, Seoul, Korea). The details of 3-D
US scanning have been described elsewhere [19e30]. In brief,
the fetus with CCAML was initially scanned by two-
dimensional (2-D) US to locate the region-of-interest (ROI).
Then, the 3-D probe was used to scan all of the ROI sys-
tematically and mechanically and the images were stored in
the laser discs for further 3-D visualization and reconstruction.
Subsequently, the 3-D images were demonstrated on the
screen. First, the multiplanar orthogonal view was illustrated.
Second, reconstructions of various modes were depicted,
including the surface-rendering mode, the transparent mode
and the maximal intensity mode.StatisticsIn order to compare the clinical characteristics at prenatal
diagnosis of CCAML between the 20th and 21st centuries in
National Cheng Kung University Hospital, Chi-square tests
were undertaken. A p value <0.05 was considered as statis-
tically significant.
Results
During the study period between October 1994 and
November 2011, 58 fetuses with CCAML were depicted by
3-D US in utero (Tables 1 and 2). Table 1 shows the cases
(total¼ 12 cases) diagnosed before January 2000, and Table 2
lists the cases (total¼ 46 cases) diagnosed from January 2000
to November 2011. The ranges of gestational age at prenatal
diagnosis of CCAML by 3-D US in the 20th century were
between 15 and 36 weeks (mean¼ 24 weeks), and were be-
tween 16 and 31 weeks (mean¼ 22 weeks) in the 21st century.
Notably, all of the cases were diagnosed after the first tri-
mester. However, nine cases (75%) were diagnosed at the
second trimester in the 20th century, but 44 cases (96%) were
diagnosed at the second trimester in the 21st century.
Furthermore, a total of 17 cases were complicated with
other additional abnormalities. As listed in Table 1, three casesg (CCAML) using 3-D US in the 20th century.
is Outcome Karyotype Associated
conditions
pe I VD 46,XX d
pe III TOP ND EIF
pe II TOP ND Heart deviation, hydrops
pe III Follow-up ND d
pe III TOP ND Heart deviation, CPC, EIF
pe III Follow-up ND d
pe II TOP 45,X/46,XX d
pe I VD 46,XX d
pe I PTL ND Fetal death
pe III VD ND d
pe III Follow-up ND d
pe III VBAC ND d
¼ follow-up at outside clinics; ND¼ not done; PTL¼ preterm labor;
¼ vaginal delivery.
Table 2
Prenatal diagnosis of fetal congenital cystic adenomatoid malformation of the lung (CCAML) using 3-D US in the 21st century.
Case no. Maternal
age (y)
Pregnancy
history
Gestational
age (wk)
US diagnosis Outcome Karyotype Associated conditions
1 28 G1P0 16 CCAML type III TOP ND Heart deviation
2 29 G1P0 17 CCAML type III TOP ND Heart deviation
3 35 G2P1 18 CCAML type III Follow-up ND d
4 28 G1P0 19 CCAML type II Follow-up ND d
5 31 G2P0A1 19 CCAML type II Follow-up ND d
6 28 G3P2 20 CCAML type III Follow-up ND d
7 24 G2P1 20 CCAML type II Follow-up ND d
8 34 G1P0 20 CCAML type II Follow-up ND EIF
9 19 G1P0 20 CCAML type III Follow-up ND d
10 21 G2P0A1 20 CCAML type III C/S 46,XY Twin pregnancy, EIF
11 28 G1P0 21 CCAML type III VD ND Poly-hydramnios
12 27 G1P0 21 CCAML type I VD 46,XX d
13 25 G1P0 21 CCAML type III Follow-up ND d
14 32 G1P0 21 CCAML type II VD 46,XX d
15 32 G2P1 21 CCAML type III Follow-up ND d
16 36 G1P0 21 CCAML type II Follow-up 46,XX d
17 30 G1P0 21 CCAML type III Follow-up 46,XX Triplet pregnancy
18 26 G3P2 21 CCAML type III Follow-up ND Heart deviation
19 27 G2P1 21 CCAML type II Follow-up ND EIF
20 29 G1P0 21 CCAML type III TOP ND d
21 25 G1P0 22 CCAML type I Follow-up 46,XX Oligo-hydramnios, IUGR
22 31 G1P0 22 CCAML type III Follow-up ND d
23 30 G1P0 22 CCAML type III VD ND d
24 23 G1P0 22 CCAML type III TOP ND d
25 32 G2P1 22 CCAML type II Follow-up ND d
26 36 G1P0 23 CCAML type III TOP 46,XY d
27 36 G3P0A2 23 CCAML type III Follow-up 46,XY d
28 30 G1P0 23 CCAML type II TOP ND Heart deviation
29 30 G2P1 23 CCAML type III Follow-up ND d
30 29 G2P1 23 CCAML type III VD 46,XX d
31 21 G3P2 23 CCAML type III Follow-up ND d
32 23 G2P1 23 CCAML type I Follow-up ND d
33 29 G1P0 23 CCAML type III Follow-up ND d
34 29 G3P2 24 CCAML type III VD ND d
35 23 G1P0 24 CCAML type III TOP ND Heart deviation
36 21 G3P1A1 24 CCAML type II TOP ND Heart deviation
37 37 G2P1 24 CCAML type III C/S 46,XX d
38 31 G1P0 24 CCAML type III TOP ND MCM EIF
39 26 G2P0A1 24 CCAML type III Follow-up 46,XY d
40 25 G2P1 25 CCAML type III Follow-up ND d
41 28 G1P0 25 CCAML type II TOP ND Hydrops
42 25 G1P0 26 CCAML type I Follow-up ND d
43 30 G2P1 27 CCAML type III Follow-up ND d
44 32 G4P3 27 CCAML type II Follow-up ND Hydrops
45 36 G2P1 31 CCAML type III C/S ND d
46 33 G1P0 31 CCAML type III Follow-up ND d
C/S¼ cesarean section; EIF¼ echogenic intracardiac focus; Follow-up¼ follow-up at outside clinics; IUGR¼ intrauterine growth retardation; MGM¼mega
cisterna magna; ND¼ not done; TOP¼ termination of pregnancy; VD¼ vaginal delivery.
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follows: heart deviation (2 cases), echogenic intracardiac focus
(2 cases), choroid plexus cyst (1 case), and hydrops fetalis (1
case). As listed in Table 2, 14 cases (30%) in the 21st century,
with associated anomalies, were as follows: heart deviation (6
cases), echogenic intracardiac focus (4 cases), polyhydramnios
(1 case), oligohydramnios (1 case), intrauterine growth retar-
dation (1 case), mega cisterna magna (1 case), and hydrops
fetalis (2 cases). Moreover, in a total of 14 fetuses with kar-
yotyping, only one case (7%) had chromosomal abnormalities
(45, X/46, XX).Both the accuracy rate of prenatal diagnosis of CCAML by
2-D and 3-D US were 100%, but 3-D US can provide additional
illustrations in 3-D after various modes of reconstruction, and
thus can depict additional abnormalities more easily and eval-
uate fetal volume more precisely. Nevertheless, the pictures of
3-D US can reveal three orthogonal planes, including coronal,
sagittal and axial views, of a fetus with CCAML, that allow the
parents to have a better understanding of the fetal malforma-
tion. Besides, the additional illustrations in 3-D US can reduce
the discrepancy in decision making and prenatal consultation
between patients and obstetricians (Figs. 1e4).
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gestational age at prenatal diagnosis of CCAML in the 21st
century was significantly earlier than that in the 20th century
( p < 0.05). The mean gestational age at prenatal diagnosis in
the 21st century was 22 weeks of gestation, while the mean
gestational age in the 20th century was 24 weeks of gestation.
Of interest, nine cases (75%) were diagnosed at the second
trimester in the 20th century, but 44 cases (96%) were diag-
nosed at the second trimester in the 21st century.
DiscussionComparison of gestational age at prenatal diagnosisFig. 2. Prenatal 2-D ultrasound of CCAML type III at 21 weeks of gestation
with heart deviation (the same case as in Fig. 1).With the development of clinical use and improvement of
reconstruction technology in 3-D US over the past decade, we
investigate if there are any differences in timing and accuracy of
the diagnosis of fetal CCAMLby 3-DUS between the centuries.
Therefore, we compared the cases of CCAML in the 20th cen-
tury with those in the 21st century (Table 3), and the results
confirmed that the gestational age at prenatal diagnosis of
CCAML in the 21st century was significantly earlier than that in
the 20th century ( p < 0.05). The possible reasons for the phe-
nomenon of earlier diagnosis of CCAML may be due to the
following factors: (1) the improvement of 3-D US machines
[19e30]; and (2) the improved technique and elevated aware-
ness of physicians. As mentioned in previous studies [19e30],
3-DUS has advantages in adding novel a visual depiction of a 3-
D lesion of a 3-D fetus in 3-D US after reconstruction, and thus
substantially assists in the prenatal consultation and genetic
screening. Besides, 3-D US is also helpful in the diagnosis of
fetal malformation and fetal dysmorphology, and has an
important impact on the fetal outcome and delivery manage-
ment [19e30]. From this series, we further validated the clinical
use of 3-D US in the prenatal diagnosis of CCAML.Fig. 1. Prenatal 2-D ultrasound of congenital cystic adenomatoid malfComparison of maternal ageIn the 20th century, only one case (8%) had advanced
maternal age, while seven cases (15%) with advanced mater-
nal age were observed in the 21st century. In the 20th century,
the mean maternal age with CCAML fetuses was 28 years,
while the mean maternal age was 28.7 years in the 21st cen-
tury. From these comparisons, the maternal age did not change
significantly between the two centuries.Comparison of associated anomaliesThere are studies which mention that microcystic lesions
may be associated with hydrops and a poor prognosis, while
fetuses with macrocystic lesions usually do not have hydrops
and are more likely to survive [14]. Nevertheless, some reports
find that the combination of polyhydramnios, fetal hydrops,ormation of the lung (CCAML) type III at 21 weeks of gestation.
Fig. 3. Prenatal 3-D ultrasound (multiplanar orthogonal view) of CCAML type III at 21 weeks of gestation (the same case as in Fig. 1).
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of increased mortality and severe respiratory compromise [15].
Moreover, 10e20% of patients with CCAML have associated
congenital abnormalities, such as esophageal atresia with
tracheoesophageal fistula, bilateral renal agenesis or dys-
genesis, intestinal atresia, other pulmonary malformations, and
diaphragmatic, cardiac, central nervous system, and bony
anomalies [16,17].
However, in our series, three cases (25%) were complicated
with other associated abnormalities in the 20th century,
including heart deviation (2 cases), echogenic intracardiac
focus (2 cases), choroid plexus cyst (1 case), and hydropsFig. 4. Prenatal 3-D ultrasound (surface render mode) of CCAMLfetalis (1 case). In the 21st century, 14 cases (30%) were
complicated with other abnormalities, namely, heart deviation
(6 cases), echogenic intracardiac focus (4 cases), poly-
hydramnios (1 case), oligohydramnios (1 case), intrauterine
growth retardation (1 case), mega cisterna magna (1 case), and
hydrops fetalis (2 cases). From these comparisons, the inci-
dence of hydrops fetalis and associated anomalies did not
change significantly between the two centuries.
On prenatal consultation of the prognosis of CCAML, the
prenatal course of CCAML depends on the gestational age,
size of the mass, amount of mediastinal shift, fetal hemody-
namics, and associated anomalies. The risk of chromosomaltype III at 21 weeks of gestation (the same case as in Fig. 1).
Table 3
Comparison of gestational age at diagnosis of fetal congenital cystic adeno-
matoid malformation of the lung (CCAML) by 3-D US.
Mean
maternal
age (y)
Second trimester
(15e28 wk)
Third
trimester
(28 wk)
Total cases
20th century
(1994e2000)
28.0 9 (75%) 3 (25%) 12 (100%)
21st century
(2000e2011)
28.7 44 (96%) 2 (4%) 46 (100%)
p¼ 0.02 by Chi-square test.
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or nonimmune hydrops [2e18]. In addition, various effects of
maternaleplacental complications and fetal aneuploidy have
to be considered on prenatal diagnosis of a congenital anomaly
[31e37]. Moreover, the impacts of fetal biometry and amni-
otic fluid amount have to be comprehensively deciphered on
the prenatal diagnosis of a congenital anomaly [38,39].
CCAML is not an exception. Therefore, it is very important
for prenatal consultation to precisely depict fetal CCAML,
with or without associated anomalies, abnormal karyotyping,
or fetal hydrops as well, as to predict fetal prognosis.
In conclusion, more cases of CCAML were detected in the
21st century, and the gestational age at prenatal diagnosis of
CCAML in the 21st century was significantly earlier that in
the last century. Over the past decades, we have engaged in the
development of the clinical use of 3-D US in fetal medicine
[19e29]. From this series, we further prove that 3-D US can
be applied in the antenatal diagnosis of a fetal congenital
anomaly, and thus has substantial advantages in clinical
medicine.
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